Delving into the Latest Updates on Tonghua Maoxiang Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study to evaluate the test formulation methotrexate tablets (strength: 2.5 mg) and the reference formulation METHOTREXATE® (strength: 2.5 mg) in healthy adult subjects in the fasting and fed state

主要研究目的：研究空腹和餐后状态下单次口服受试制剂甲氨蝶呤片（规格：2.5 mg，通化茂祥制药有限公司生产）与参比制剂甲氨蝶呤片（METHOTREXATE®，规格：2.5 mg，ファイザー株式会社生产）在健康受试者体内的药代动力学特征，评价空腹和餐后状态口服两种制剂的生物等效性。次要研究目的：研究受试制剂甲氨蝶呤片（规格：2.5 mg）和参比制剂METHOTREXATE®（规格：2.5 mg）在健康受试者中的安全性。

[Translation]

The main purpose of the study is to study the pharmacokinetic characteristics of the test preparation methotrexate tablets (specification: 2.5 mg, produced by Tonghua Maoxiang Pharmaceutical Co., Ltd.) and the reference preparation methotrexate tablets (METHOTREXATE®, specification: 2.5 mg, produced by ファイザー Co., Ltd.) in healthy subjects after a single oral administration in the fasting and fed state, and to evaluate the bioequivalence of the two preparations in the fasting and fed state. Secondary purpose of the study: to study the safety of the test preparation methotrexate tablets (specification: 2.5 mg) and the reference preparation METHOTREXATE® (specification: 2.5 mg) in healthy subjects.

Start Date26 Sep 2024

Sponsor / Collaborator

Tonghua Maoxiang Pharmaceutical Co. Ltd.

CTR20150375

/ CompletedPhase 4

进一步评价氯氧喹胶囊治疗乳腺癌和非小细胞肺癌的安全性和有效性的多中心Ⅳ期临床试验

[Translation] A multicenter phase IV clinical trial to further evaluate the safety and efficacy of chloroquine capsules in the treatment of breast cancer and non-small cell lung cancer

进一步评价氯氧喹胶囊治疗乳腺癌和非小细胞肺癌的安全性和有效性。

[Translation]

To further evaluate the safety and efficacy of chloroquine capsules in the treatment of breast cancer and non-small cell lung cancer.

Start Date07 Jun 2014

Sponsor / Collaborator

Tonghua Maoxiang Pharmaceutical Co. Ltd.

CTR20131817

/ CompletedPhase 4

进一步评价氯氧喹胶囊治疗晚期乳腺癌和中晚期非小细胞肺癌的安全性和有效性的多中心Ⅳ期临床试验

[Translation] A multicenter phase IV clinical trial to further evaluate the safety and efficacy of chloroquine capsules in the treatment of advanced breast cancer and advanced non-small cell lung cancer

进一步评价氯氧喹胶囊治疗晚期乳腺癌和中晚期非小细胞肺癌的安全性和有效性。

[Translation]

To further evaluate the safety and efficacy of chloroquine capsules in the treatment of advanced breast cancer and advanced non-small cell lung cancer.

Start Date22 Oct 2010

Sponsor / Collaborator

Tonghua Maoxiang Pharmaceutical Co. Ltd.

100 Clinical Results associated with Tonghua Maoxiang Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Tonghua Maoxiang Pharmaceutical Co. Ltd.

Login to view more data

1

Literatures (Medical) associated with Tonghua Maoxiang Pharmaceutical Co. Ltd.

Shandong Huagong

Process for production of borax pentahydrate

Author: Wang, Xiang-dong

A new process for production of borax pentahydrate is presented.

100 Deals associated with Tonghua Maoxiang Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Tonghua Maoxiang Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data